TG Therapeutics - 株価

TGTX

44.78

毎日の変更:

-2.29%

毎年:

282.08%

価格 日 年
AbbVie 107.91 1.02 0.95% 29.31%
Amgen 255.71 0.58 0.23% 8.83%
Ardelyx 8.69 0.03 0.35% 23.44%
Arena Pharmaceuticals 65.90 -2.09 -3.07% 32.52%
Arrowhead Research 67.65 -0.33 -0.49% 85.09%
Bayer 54.00 1.12 2.12% -7.80%
Biogen 270.31 -0.13 -0.05% -21.09%
Corcept Therapeutics 22.77 -0.18 -0.76% 80.10%
Curis 11.49 -0.72 -5.90% 1,354.43%
Dynavax Technologies 10.99 0.13 1.20% 223.24%
Gilead Sciences 66.87 1.10 1.67% -20.38%
Intercept Pharmaceuticals 20.28 -0.27 -1.31% -75.05%
Infinity Pharmaceuticals 2.98 -0.10 -3.25% 217.02%
Johnson & Johnson 162.24 1.85 1.15% 6.72%
Karyopharm Therapeutics 9.71 0.02 0.21% -58.58%
Novartis 80.87 0.34 0.42% -5.97%
Novavax 227.35 25.26 12.50% 1,091.56%
Puma Biotechnology 10.07 -0.14 -1.37% 4.35%
PTC Therapeutics 48.59 0.40 0.83% -2.39%
Regeneron Pharmaceuticals 502.60 7.96 1.61% -11.64%
Roche Holding 309.20 -0.30 -0.10% -5.40%
Spectrum Pharmaceuticals 3.00 0.02 0.67% 9.49%
TG Therapeutics 44.78 -1.05 -2.29% 282.08%
Vertex Pharmaceuticals 219.39 -1.71 -0.77% -18.88%
Verastem 2.68 -0.01 -0.37% -15.72%
Acceleron Pharma 122.05 -1.98 -1.60% 24.82%
Ziopharm Oncology 3.33 -0.10 -2.77% 15.03%

価格 日 年
NASDAQ 14052 13.58 0.10% 62.45%
Russell 2000 2262 5.60 0.25% 84.09%

TGTX:US
資産
現金と同等
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
貿易債務者